Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_provenance.
- NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_assertion description "[We found that inhibitory receptor KIR2DL1 in combination with HLA-C2 ligand confers susceptibility to chronic hepatitis B (CHB), whereas inhibitory receptor KIR2DL3 or KIR2DL3 homozygote in the presence of HLA-C1C1 genotype shows protection against CHB.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_provenance.
- NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_assertion evidence source_evidence_literature NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_provenance.
- NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_assertion SIO_000772 20643584 NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_provenance.
- NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_assertion wasDerivedFrom gad-20130706 NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_provenance.
- NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_assertion wasGeneratedBy ECO_0000203 NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_provenance.
- gad-20130706 importedOn "2013-07-06" NP85489.RAKwJ65w4JlUiBT2QpCsHm07Ly40rFWx4opuTiuek7n9s130_provenance.